| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/25/2007 | EP1309626B1 Cng2b: a putative human cyclic nucleotide-gated ion channel |
| 04/25/2007 | EP1294888B1 Interferon-like protein zcyto21 |
| 04/25/2007 | EP1259813B1 Diagnosis of malignant neoplasms |
| 04/25/2007 | EP1223964B1 April receptor (bcma) and uses thereof |
| 04/25/2007 | EP1210425B1 Baff receptor (bcma), an immunoregulatory agent |
| 04/25/2007 | EP1190056B1 Human cytokine receptor |
| 04/25/2007 | EP1045904B1 Fatty acid transport proteins |
| 04/25/2007 | EP1033134B1 Compositions inhibiting smooth muscle proliferation and method for the diagnosis of arteriosclerosis |
| 04/25/2007 | EP1000177B1 Synthetic antigens for the detection of antibodies having immunoreactivity against hiv virus |
| 04/25/2007 | EP0984023B1 Cell surface molecule mediating cell adhesion and signal transmission |
| 04/25/2007 | EP0925358B1 Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use |
| 04/25/2007 | EP0901526B1 Cortistatin: neuropeptides, compositions and methods |
| 04/25/2007 | CN1954074A Process for producing polypeptides |
| 04/25/2007 | CN1954073A Modified Bouganin proteins, cytotoxins and methods and uses thereof |
| 04/25/2007 | CN1953988A Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides |
| 04/25/2007 | CN1953783A Treatment of diseases |
| 04/25/2007 | CN1953768A Highly concentrated liquid formulations of anti-EGFR antibodies |
| 04/25/2007 | CN1952140A Cloning of Japanese blood fluke vaccine antigen gene and its expression and application |
| 04/25/2007 | CN1952135A Polynucleotide related to cell multiplication and its encoded polypeptide and application |
| 04/25/2007 | CN1952134A Polynucleotide promoting activity of human transcription factor NF-kappa B and its encoded polypeptide and application |
| 04/25/2007 | CN1952133A Polynucleotide activating ELK1 activity and its encoded polypeptide and application |
| 04/25/2007 | CN1952132A Polynucleotide having influence on ELK1 activity and its encoded polypeptide and application |
| 04/25/2007 | CN1952131A Neural protein NSPc1 having influence on nerve tumor cell differentiation by tretinoin signal pathway |
| 04/25/2007 | CN1952130A Liver cancer high-expression gene PEG10, its encoded protein and use |
| 04/25/2007 | CN1952127A Application of BPY2IP1 gene in inhibiting CRE activation |
| 04/25/2007 | CN1952121A Candida albicans CTD protein kinase gene and application therefor |
| 04/25/2007 | CN1951967A Monoclonal antibody for resisting human osteogenesis induction factor and its preparation method and uses |
| 04/25/2007 | CN1951966A Zn-finger protein HZF1 antibody |
| 04/25/2007 | CN1951962A Polypeptide for preparing antineoplastic antibody and its uses |
| 04/25/2007 | CN1951398A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 04/25/2007 | CN1312908C Digital camera |
| 04/25/2007 | CN1312182C Monoclone antibody for anti HLA-G and hybrid tumour cell secreting same, cancer dignosis reagent box and its application |
| 04/25/2007 | CN1312181C Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 04/25/2007 | CN1312180C Lefteye flonder lymphocystic virus neutralizing monoclonal antibody and its preparing method |
| 04/25/2007 | CN1312177C Tumour related protein antigen epitope and its coding gene and uses |
| 04/25/2007 | CN1311871C DNA expression vectors and methods of use |
| 04/24/2007 | USRE39586 Secreted by the hybridoma cell line deposited in the Cell; Peripheral blood lymphocytes are activated in vitro with pokeweed mitogen and then fused with heteromyeloma cells to generate hybridomas secreting human antibodies |
| 04/24/2007 | US7208585 Using hydrophobic charge induction chromatography to isolate preferential immunoglobulins in mixture; rationally designed liquid chromatography |
| 04/24/2007 | US7208584 Fibroblast growth factor-13 |
| 04/24/2007 | US7208583 Analyzing, screening for cancer, genetic defects; diagnosis of mutants |
| 04/24/2007 | US7208582 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents |
| 04/24/2007 | US7208581 TRAF family proteins |
| 04/24/2007 | US7208577 Methods of increasing lean tissue mass using OB protein compositions |
| 04/24/2007 | US7208475 Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 04/24/2007 | US7208466 Treating pain or inflammation; inhibiting C-fibre neuron activity; hemagglutinins conjugated with protein |
| 04/24/2007 | US7208321 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics |
| 04/24/2007 | US7208312 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2007 | US7208308 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2007 | US7208301 Method for producing 6-0-α-D-glucopyranosyl-D-sorbitol |
| 04/24/2007 | US7208300 Enzymatic polypetide for use in the treatment of aneurysms and artheroslerosis |
| 04/24/2007 | US7208281 Ligands used for detecting prions |
| 04/24/2007 | US7208280 Controlling gene expression in tissue |
| 04/24/2007 | US7208273 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia |
| 04/24/2007 | US7208270 Detecting demyelinating nervous system disorder by measurement of stem cell factor (SCF)-apoptosis-response gene protein(SARG-1-) protein; antiproliferative agents; microtubule associated protein 1(map1a); cancer screening |
| 04/24/2007 | US7208267 Compositions and methods relating to breast specific genes and proteins |
| 04/24/2007 | US7208174 Liposome compositions |
| 04/24/2007 | US7208162 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents |
| 04/24/2007 | US7208156 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule |
| 04/24/2007 | US7208153 Method for the improvement of neuronal regeneration |
| 04/24/2007 | US7208152 Antibodies for “Bonzo” chemokine receptor and therapeutic uses thereof |
| 04/24/2007 | US7208151 Antitumor agents; monoclonal antibodies |
| 04/24/2007 | US7208150 Non-toxic fraction isolated from the venom of Vipera xanthina, for therapy of pain |
| 04/24/2007 | US7208149 IL-16 antagonist peptides and DNA encoding the peptides |
| 04/24/2007 | US7208146 Vaccine comprising at least two recombinant variable regions of immunoglobulin molecules derived from B-cell lymphoma cells, wherein cells express at least two different immunoglobulin molecules differing by one idiotype |
| 04/24/2007 | CA2236482C Expression of cyclin g1 in tumors |
| 04/19/2007 | WO2007044940A2 Antibody against a peptide derived from human mutant lamin a protein and uses thereof |
| 04/19/2007 | WO2007044887A2 Method for producing a population of homogenous tetravalent bispecific antibodies |
| 04/19/2007 | WO2007044756A2 Monoclonal antibodies recognizing human ccr8 |
| 04/19/2007 | WO2007044695A2 ANTIBODIES AGAINST SARS-CoV AND METHODS OF USE THEREOF |
| 04/19/2007 | WO2007044616A2 Optimized anti-cd30 antibodies |
| 04/19/2007 | WO2007044411A2 Anti-myostatin antibodies |
| 04/19/2007 | WO2007044115A2 Improved chimeric toxin receptor proteins and chimeric toxin receptor proteins for treatment and prevention of anthrax |
| 04/19/2007 | WO2007043792A1 A monoclonal antibody for detection of hydroxylated asparagine 803 of hif-1 alpha and antigen peptide |
| 04/19/2007 | WO2007043635A1 Preventive/remedy for cancer |
| 04/19/2007 | WO2007043582A1 Method for determination of sars virus nucleocapsid protein, reagent kit for the determination, test device, monoclonal antibody directed against sars virus nucleocapsid protein, and hybridoma capable of producing the monoclonal antibody |
| 04/19/2007 | WO2007043531A1 Genetic marker for use in diagnosis of sensitivity to anti-tumor agent or concurrent chemoradiation therapy, and use thereof |
| 04/19/2007 | WO2007042809A2 Antibody polypeptide library screening and selected antibody polypeptides |
| 04/19/2007 | WO2007042573A2 Compositions and methods for treating proliferative disorders |
| 04/19/2007 | WO2007042524A2 Treating diabetes using inhibitors of il-1 |
| 04/19/2007 | WO2007042289A2 Nanobodies™ and polypeptides against egfr and igf-ir |
| 04/19/2007 | WO2007041861A1 Chimeric antigen containing hepatitis c virus polypeptide and fc fragment for eliciting an immune response |
| 04/19/2007 | WO2007024535A3 Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8-associated disorders |
| 04/19/2007 | WO2007024535A2 Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8-associated disorders |
| 04/19/2007 | WO2007016285A3 M-csf specific monoclonal antibody and uses thereof |
| 04/19/2007 | WO2007015691A9 Methods and compositions for increasing longevity and protein yield from a cell culture |
| 04/19/2007 | WO2007014992A3 Antibodies directed against an ldl receptor |
| 04/19/2007 | WO2007014344A3 Detection and measurement of blood-feeding activity |
| 04/19/2007 | WO2007002223A3 Cd19 antibodies and their uses |
| 04/19/2007 | WO2006133398A3 In vitro activated donor t-cells to promote transplant engraftment |
| 04/19/2007 | WO2006129843A3 Bispecific capturing molecule |
| 04/19/2007 | WO2006122797B1 Anti-gm-csf antibodies and uses therefor |
| 04/19/2007 | WO2006116592A3 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells |
| 04/19/2007 | WO2006116541A3 Tat-002 and methods of assessing and treating cancer |
| 04/19/2007 | WO2006111353A3 Antibody neutralizers of human granulocyte macrophage colony stimulating factor |
| 04/19/2007 | WO2006099481A3 Macromolecules comprising a thioether cross-link |
| 04/19/2007 | WO2006086469A3 Antibodies to tgfbeta |
| 04/19/2007 | WO2006077471A3 Combining therapies targeting multiple toll-like receptors and use thereof |
| 04/19/2007 | WO2006076594A3 Antibodies and fc fusion proteins with altered immunogenicity |
| 04/19/2007 | WO2006053155A3 Gp202: methods and compositions for treating cancer |
| 04/19/2007 | WO2006047639A3 Modulation of antibody specificity by tailoring the affinity to cognate antigens |